跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
DEFUZIN CREAM 2% W/W
Approved
THERAPEUTIC
DEFUZIN CREAM 2% W/W
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
🇸🇬 Health Sciences Authority
Approval Date
Feb 1, 2019
Approval ID
6cc3083fce55dc0d
Company
XEPA-SOUL PATTINSON (MALAYSIA) SDN BHD (MALAYSIA)
Type
Therapeutic
Approval Details
Approval Id
6cc3083fce55dc0d
Drug Name
DEFUZIN CREAM 2% W/W
Product Name
DEFUZIN CREAM 2% W/W
Approval Number
SIN15620P
Approval Date
2019-02-01
Registrant
APEX PHARMA MARKETING PTE. LTD.
Licence Holder
APEX PHARMA MARKETING PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
CREAM
Route Of Administration
TOPICAL
Atc Code
D06AX01
Atc Item Name
fusidic acid
Pharma Manufacturer Name
APEX PHARMA MARKETING PTE. LTD.
Active Ingredients
FUSIDIC ACID (MICRONISED)
2.00% w/w
FUSIDIC ACID (MICRONISED)
2% W/W
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Feb 1, 2019
Approval ID
6cc3083fce55dc0d
Type
Therapeutic
Back to HSA Approvals
DEFUZIN CREAM 2% W/W - HSA Drug Approval Details